33 results on '"Faria, Vanda"'
Search Results
2. Migraine with aura: less control over pain and fragrances?
- Author
-
Mignot, Coralie, Faria, Vanda, Hummel, Thomas, Frost, Marie, Michel, Christoph M., Gossrau, Gudrun, and Haehner, Antje
- Published
- 2023
- Full Text
- View/download PDF
3. Functional connectivity differences in healthy individuals with different well-being states
- Author
-
Joshi, Akshita, Thaploo, Divesh, Hornstein, Henriette, Chao, Yun-Ting, Faria, Vanda, Warr, Jonathan, and Hummel, Thomas
- Published
- 2023
- Full Text
- View/download PDF
4. Placebos in pediatrics: A cross-sectional survey investigating physicians' perspectives
- Author
-
Faria, Vanda, Talbert, Cameron, Goturi, Nathan, Borsook, David, Lebel, Alyssa, Kaptchuk, Ted J., Kirsch, Irving, Kelley, John M., and Moulton, Eric A.
- Published
- 2023
- Full Text
- View/download PDF
5. Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy
- Author
-
Hjorth, Olof, Frick, Andreas, Gingnell, Malin, Engman, Jonas, Björkstrand, Johannes, Faria, Vanda, Alaie, Iman, Carlbring, Per, Andersson, Gerhard, Jonasson, My, Lubberink, Mark, Antoni, Gunnar, Reis, Margareta, Wahlstedt, Kurt, Fredrikson, Mats, and Furmark, Tomas
- Published
- 2022
- Full Text
- View/download PDF
6. Expression and co-expression of serotonin and dopamine transporters in social anxiety disorder: a multitracer positron emission tomography study
- Author
-
Hjorth, Olof R., Frick, Andreas, Gingnell, Malin, Hoppe, Johanna M., Faria, Vanda, Hultberg, Sara, Alaie, Iman, Månsson, Kristoffer N. T., Wahlstedt, Kurt, Jonasson, My, Lubberink, Mark, Antoni, Gunnar, Fredrikson, Mats, and Furmark, Tomas
- Published
- 2021
- Full Text
- View/download PDF
7. Sex and age-related patterns in pediatric primary headaches: observations from an outpatient headache clinic.
- Author
-
Faria, Vanda, Höfer, Berit, Klimova, Anna, von der Hagen, Maja, Berner, Reinhard, Sabatowski, Rainer, Koch, Thea, Hübler, Anke, Richter, Matthias, Moulton, Eric A., Holmes, Scott A., and Gossrau, Gudrun
- Subjects
PRIMARY headache disorders ,TEENAGE girls ,MIGRAINE ,MIGRAINE aura ,CONSCIOUSNESS raising - Abstract
Background: Age reportedly affects headache prevalence differently in boys and girls. However, little empirical data exists regarding pediatric headache prevalence and headache-related burden in children and adolescents according to age and sex. In the present study, we considered age and sex while evaluating the distribution, characteristics, and impairment of primary headache disorders at a pediatric headache center in Germany. Methods: Medical records of children and adolescents attending the headache clinic of the Interdisciplinary Pain Center of the Carl Gustav Carus University Hospital in Dresden during the period 2015-2022 were retrospectively grouped and analyzed depending on age (< or ≥14 years) and sex. Results: The study population consisted of 652 children and adolescents, aged between 3 and 18 years. Almost two-thirds of the patients (≈60%) were females, and almost two-thirds of these females (58%) were ≥14 years of age. Generally, the most prevalent headache diagnoses as defined by the International Classification of Headache Disorders 3rd edition were episodic migraine without aura and the combination of tension-type headache and episodic migraine with or without aura i.e., mixed-type headache (each ≈27%). In the younger group (<14 years), the mixed-type headache was the most prevalent in girls (28.6%), whereas, for boys, episodic migraine without aura was the most prevalent headache diagnosis (47.4%). In the older group (≥14 years), the mixed-type headache continued to be the most prevalent for girls (30%), and it became the most prevalent for boys (26.3%). Before the age of 14, about 16% of children were severely affected by their headaches. After the age of 14, this proportion increased to roughly one-third (33%) of adolescents, driven mainly by teenage girls (26%) who were severely affected by their headaches. Furthermore, the prevalence of comorbidities was significantly higher among girls (67%), particularly in the adolescent group (74%). Conclusions: Our data shows that headache disorders in a specialized pediatric clinic impose a significant burden, especially among teenage girls indicating high therapy needs. Enhancing awareness of early diagnosis and preventive care is crucial to mitigate the development of chronic headaches, and mitigate their adverse effects on life quality and educational capability. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Verbal suggestions of nicotine content modulate ventral tegmental neural activity during the presentation of a nicotine-free odor in cigarette smokers
- Author
-
Faria, Vanda, Han, Pengfei, Joshi, Akshita, Enck, Paul, and Hummel, Thomas
- Published
- 2020
- Full Text
- View/download PDF
9. Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder: a randomized clinical trial
- Author
-
Hjorth, Olof R., Frick, Andreas, Gingnell, Malin, Hoppe, Johanna M., Faria, Vanda, Hultberg, Sara, Alaie, Iman, Månsson, Kristoffer N. T., Rosén, Jörgen, Reis, Margareta, Wahlstedt, Kurt, Jonasson, My, Lubberink, Mark, Antoni, Gunnar, Fredrikson, Mats, and Furmark, Tomas
- Published
- 2021
- Full Text
- View/download PDF
10. Parental Attitudes About Placebo Use in Children
- Author
-
Faria, Vanda, Kossowsky, Joe, Petkov, Mike P., Kaptchuk, Ted J., Kirsch, Irving, Lebel, Alyssa, and Borsook, David
- Published
- 2017
- Full Text
- View/download PDF
11. Neural processing of olfactory-related words in subjects with congenital and acquired olfactory dysfunction
- Author
-
Joshi, Akshita, Han, Pengfei, Faria, Vanda, Larsson, Maria, and Hummel, Thomas
- Published
- 2020
- Full Text
- View/download PDF
12. Neuroimaging the Development of Olfactory Function in a Woman With No Olfactory Bulbs.
- Author
-
Faria, Vanda, Joshi, Akshita, Mignot, Coralie, Thaploo, Divesh, Weise, Susanne, and Hummel, Thomas
- Published
- 2024
- Full Text
- View/download PDF
13. Combining escitalopram and cognitive–behavioural therapy for social anxiety disorder: randomised controlled fMRI trial
- Author
-
Gingnell, Malin, Frick, Andreas, Engman, Jonas, Alaie, Iman, Björkstrand, Johannes, Faria, Vanda, Carlbring, Per, Andersson, Gerhard, Reis, Margareta, Larsson, Elna-Marie, Wahlstedt, Kurt, Fredrikson, Mats, and Furmark, Tomas
- Published
- 2016
- Full Text
- View/download PDF
14. Neural Processing of Odors with Different Well-Being Associations—Findings from Two Consecutive Neuroimaging Studies.
- Author
-
Joshi, Akshita, Hornstein, Henriette, Thaploo, Divesh, Faria, Vanda, Warr, Jonathan, and Hummel, Thomas
- Subjects
PARIETAL lobe ,PREFRONTAL cortex ,CINGULATE cortex ,WELL-being ,EMOTIONAL conditioning ,STIMULUS & response (Psychology) - Abstract
Much is known about the effect of odors on mood, cognition and behavior, but little is known about the relationship between odors and well-being. We investigated the neural processing of odors with different degrees of association with well-being (WB) through two large independent datasets. The study encompassed pre-testing and fMRI. During pre-testing, 100 and 80 (studies 1 and 2) young, healthy subjects participated, rating intensity, valence, and WB association for 14 (study 1) and 8 (study 2) different odors. Pre-testing resulted in the selection of two odors with high WB association (WB-associated) and two odors with lower WB association (neutral odors) for each study. Odors were delivered intranasally to the subjects who underwent fMRI scanning (44 and 41 subjects, respectively, for studies 1 and 2). We assessed brain activity for subjects when they experienced WB-associated versus neutral odors. In study 1, WB-associated odors showed increased activation in the right angular gyrus whereas in study 2, increased activity in the left angular gyrus existed, together with increased activity in the anterior cingulate cortex and posterior orbitofrontal cortex. The increased activity of higher-order cognitive and emotional regions during the processing of WB-associated odors in the two independent studies suggests a role of odors in influencing individual well-being. Moreover, the consistent activation of the angular gyrus might suggest its key role in shifting attention toward relevant emotional stimuli. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
15. Serotonin Synthesis and Reuptake in Social Anxiety Disorder: A Positron Emission Tomography Study
- Author
-
Frick, Andreas, Åhs, Fredrik, Engman, Jonas, Jonasson, My, Alaie, Iman, Björkstrand, Johannes, Frans, Örjan, Faria, Vanda, Linnman, Clas, Appel, Lieuwe, Wahlstedt, Kurt, Lubberink, Mark, Fredrikson, Mats, and Furmark, Tomas
- Published
- 2015
- Full Text
- View/download PDF
16. Imaging the placebo response: A neurofunctional review
- Author
-
Faria, Vanda, Fredrikson, Mats, and Furmark, Tomas
- Published
- 2008
- Full Text
- View/download PDF
17. Harnessing the Placebo Effect in Pediatric Migraine Clinic
- Author
-
Faria, Vanda, Linnman, Clas, Lebel, Alyssa, and Borsook, David
- Published
- 2014
- Full Text
- View/download PDF
18. Genotype over-diagnosis in amygdala responsiveness: affective processing in social anxiety disorder
- Author
-
Furmark, Tomas, Henningsson, Susanne, Appel, Lieuwe, Ahs, Fredrik, Linnman, Clas, Pissiota, Anna, Faria, Vanda, Oreland, Lars, Bani, Massimo, Pich, Emilio Merlo, Eriksson, Elias, and Fredrikson, Mats
- Subjects
Social phobia -- Physiological aspects ,Social phobia -- Psychological aspects ,Amygdala (Brain) -- Properties ,Human information processing -- Research - Abstract
Background: Although the amygdala is thought to be a crucial brain region for negative affect, neuroimaging studies do not always show enhanced amygdala response to aversive stimuli in patients with anxiety disorders. Serotonin (5-HT)-related genotypes may contribute to interindividual variability in amygdala responsiveness. The short (s) allele of the 5-HT transporter linked polymorphic region (5-HTTLPR) and the T variant of the G-703T polymorphism in the tryptophan hydroxylase-2 (TPH2) gene have previously been associated with amygdala hyperresponsivity to negative faces in healthy controls. We investigated the influence of these polymorphisms on amygdala responsiveness to angry faces in patients with social anxiety disorder (SAD) compared with healthy controls. Methods: We used positron emission tomography with oxygen 15-labelled water to assess regional cerebral blood flow in 34 patients with SAD and 18 controls who viewed photographs of angry and neutral faces presented in counterbalanced order. We genotyped all participants with respect to the 5-HTTLPR and TPH2 polymorphisms. Results: Patients with SAD and controls had increased left amygdala activation in response to angry compared with neutral faces. Genotype but not diagnosis explained a significant portion of the variance in amygdala responsiveness, the response being more pronounced in carriers of s and/or T alleles. Limitations: Our analyses were limited owing to the small sample and the fact that we were unable to match participants on genotype before enrolment. In addition, other imaging techniques not used in our study may have revealed additional effects of emotional stimuli. Conclusion: Amygdala responsiveness to angry faces was more strongly related to serotonergic polymorphisms than to diagnosis of SAD. Emotion activation studies comparing amygdala excitability in patient and control groups could benefit from taking variation in 5-HT-related genes into account. Contexte: Meme si l'on considere l'amygdale comme une region du cerveau cruciale pour l'affect negatif, les epreuves de neuroimagerie ne revelent pas toujours un rehaussement de la reactivite amygdalienne aux stimuli aversifs chez les patients souffrant de troubles anxieux. Les genotypes lies a la serotonine (5-HT) pourraient contribuer a la variabilite interindividuelle de la reponse amygdalienne. L'allele (s) court du gene polymorphe 5-HTTLPR (serotonin-transporter-linked polymorphic region), un transporteur de la 5-HT, et la variante T du polymorphisme G-703T du gene TPH2 (tryptophan hydroxylase-2) ont ete associes anterieurement a une hyperreactivite amygdalienne aux visages exprimant une emotion negative chez des temoins en bonne sante. Nous avons voulu mesurer l'influence de ces polymorphismes sur la reactivite amygdalienne aux visages exprimant la colere chez des patients atteints de phobie sociale, comparativement a des temoins en bonne sante. Methodes : Nous avons utilise la tomographie par emission de positrons avec de l'eau radioactive marquee a l'oxygene 15 pour mesurer le debit sanguin cerebral regional chez 34 patients souffrant de phobie sociale et 18 temoins a qui l'on presentait des photographies de visages en colere ou neutres en sequence contrebalancees. Nous avons etabli le genotype de tous les participants pour ce qui est des polymorphismes 5-HTTLPR et TPH2. Resultats : Les patients souffrant de phobie sociale et les temoins ont presente une activation amygdalienne gauche accrue en reponse aux visages en colere, par rapport aux visages neutres. Il a ete possible d'expliquer une portion significative de la variance de la reactivite amygdalienne par le genotype, mais non par le diagnostic, la reponse ayant ete plus prononcee chez les porteurs des alleles s ou T. Limites : Nos analyses ont ete limitees en raison du petit echantillon et du fait que nous n'ayons pas pu assortir les participants selon leurs genotypes avant leur inscription a l'etude. De plus, d'autres techniques d'imagerie, non utilisees lors de notre etude, auraient pu reveler certains effets additionnels des stimuli emotionnels. Conclusion : La reactivite amygdalienne aux visages exprimant la colere a ete plus intimement liee aux polymorphismes serotoninergiques qu'au diagnostic de phobie sociale. Les etudes d'activation des emotions comparant l'excitabilite de l'amygdale chez des groupes de patients et de temoins pourraient utiliser avantageusement les variations des genes lies a la 5-HT., Introduction The amygdala has long been associated with fear reactions and detection of danger signals. (1) Studies in animals and humans have confirmed that the amygdala is a critical structure [...]
- Published
- 2009
19. In a Nervous Voice: Acoustic Analysis and Perception of Anxiety in Social Phobics’ Speech
- Author
-
Laukka, Petri, Linnman, Clas, Åhs, Fredrik, Pissiota, Anna, Frans, Örjan, Faria, Vanda, Michelgård, Åsa, Appel, Lieuwe, Fredrikson, Mats, and Furmark, Tomas
- Published
- 2008
- Full Text
- View/download PDF
20. Symptoms of Depression in Patients with Chemosensory Disorders.
- Author
-
Chen, Ben, Benzien, Cara, Faria, Vanda, Ning, Yuping, Cuevas, Mandy, Linke, Jana, Croy, Ilona, Haehner, Antje, and Hummel, Thomas
- Subjects
SMELL ,TASTE disorders ,MULTIPLE regression analysis ,BECK Depression Inventory ,MENTAL depression ,SMELL disorders ,PSYCHOLOGICAL tests ,TASTE - Abstract
Introduction: Patients with chemosensory dysfunction frequently report symptoms of depression. The current study aims to clarify whether the type (smell dysfunction, taste dysfunction, and mixed smell and taste dysfunction), severity, duration, or cause of dysfunction have differential impacts on the symptoms of depression.Methods: 899 patients with chemosensory disorders and 62 controls were included. Following a structured interview and an otorhinolaryngological examination, subjects underwent olfactory tests (Sniffin' Sticks), gustatory tests (taste sprays) and an assessment of depressive symptoms (Beck Depression Inventory). Information on the cause and duration of disorders was also collected.Results: Patients with combined olfactory/gustatory dysfunction had higher depression scores than patients with smell dysfunction only and controls, and no significant difference was found between the smell dysfunction and controls. Anosmia patients, but not hyposmia patients, exhibited higher depression scores than controls. Among various causes of chemosensory disorders, patients from the posttraumatic group had higher depression scores than patients with other causes of chemosensory dysfunction (sinonasal, idiopathic, or postinfectious). Multiple linear regression analyses suggested that reduced olfactory function was associated with enhanced depression scores in the olfactory disorders group (B = -0.326, t = -2.294, and p = 0.02) and in all patients with chemosensory disorders (B = -0.374, t = -2.550, p = 0.017).Discussion/conclusion: Simultaneously decreased input of olfaction and gustation seems to have an additive effect on the exacerbation of emotional dysfunction. Early intervention should be considered for depression symptoms in patients with mixed olfactory/gustatory dysfunction in clinical practice. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
21. Short or long runs: An exploratory study of odor-induced fMRI design.
- Author
-
Han, Pengfei, Zang, Yunpeng, Hummel, Cornelia, Faria, Vanda, and Hummel, Thomas
- Abstract
Objective: Functional magnetic resonance imaging (fMRI) is a non-invasive neuroimaging technique widely used in olfactory research. During a typical fMRI olfactory block-design, one functional "run" refers to a combination of multiple blocks with continuous brain image acquisition. The current study investigated the length of functional runs on odor-induced brain response signals (blood oxygen level dependent [BLOD]) within the primary and key secondary olfactory areas.Methods: Twenty-five female adults (age range 19 to 30 years, mean age 25 years) underwent a block-design fMRI measurement with odor stimulation. Twelve participants received the odor stimuli within a short run paradigm (six blocks in each 4-minute run, eight runs in total), and 13 participants received the odor stimulation with a long-run paradigm (12 blocks in each 8-minute run, four runs in total). For each paradigm, two odors (peach and rose) were alternatingly presented between runs. Participants rated odor intensity and pleasantness at the end of each run. Ratings and fMRI data were analyzed for different subsections and compared between groups.Results: There was a higher level of brain activation in the insula and orbitofrontal cortex during the short-run paradigm as compared to the long-run paradigm. However, there was no difference for odor intensity or pleasantness ratings.Conclusion: The current study suggested the employment of short runs with multiple repetitions for odor stimulation during fMRI research.Level Of Evidence: 3 Laryngoscope, 130:1110-1115, 2020. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
22. Higher- and lower-order personality traits and cluster subtypes in social anxiety disorder.
- Author
-
Costache, Mădălina Elena, Frick, Andreas, Månsson, Kristoffer, Engman, Jonas, Faria, Vanda, Hjorth, Olof, Hoppe, Johanna M., Gingnell, Malin, Frans, Örjan, Björkstrand, Johannes, Rosén, Jörgen, Alaie, Iman, Åhs, Fredrik, Linnman, Clas, Wahlstedt, Kurt, Tillfors, Maria, Marteinsdottir, Ina, Fredrikson, Mats, and Furmark, Tomas
- Subjects
SOCIAL anxiety ,PERSONALITY ,ANXIETY disorders ,SPEECH anxiety ,LOGISTIC regression analysis ,LATENT class analysis (Statistics) - Abstract
Social anxiety disorder (SAD) can come in different forms, presenting problems for diagnostic classification. Here, we examined personality traits in a large sample of patients (N = 265) diagnosed with SAD in comparison to healthy controls (N = 164) by use of the Revised NEO Personality Inventory (NEO-PI-R) and Karolinska Scales of Personality (KSP). In addition, we identified subtypes of SAD based on cluster analysis of the NEO-PI-R Big Five personality dimensions. Significant group differences in personality traits between patients and controls were noted on all Big Five dimensions except agreeableness. Group differences were further noted on most lower-order facets of NEO-PI-R, and nearly all KSP variables. A logistic regression analysis showed, however, that only neuroticism and extraversion remained significant independent predictors of patient/control group when controlling for the effects of the other Big Five dimensions. Also, only neuroticism and extraversion yielded large effect sizes when SAD patients were compared to Swedish normative data for the NEO-PI-R. A two-step cluster analysis resulted in three separate clusters labelled Prototypical (33%), Introvert-Conscientious (29%), and Instable-Open (38%) SAD. Individuals in the Prototypical cluster deviated most on the Big Five dimensions and they were at the most severe end in profile analyses of social anxiety, self-rated fear during public speaking, trait anxiety, and anxiety-related KSP variables. While additional studies are needed to determine if personality subtypes in SAD differ in etiological and treatment-related factors, the present results demonstrate considerable personality heterogeneity in socially anxious individuals, further underscoring that SAD is a multidimensional disorder. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
23. The migraine brain in transition: girls vs boys.
- Author
-
Faria, Vanda, Erpelding, Nathalie, Lebel, Alyssa, Johnson, Adriana, Wolff, Robert, Fair, Damien, Burstein, Rami, Becerr, Lino, Borsook, David, and Becerra, Lino
- Subjects
- *
MIGRAINE , *HEADACHE treatment , *DISEASE prevalence , *MAGNETIC resonance imaging of the brain , *NEURAL circuitry , *BRAIN function localization , *PHENOTYPES , *AGE distribution , *BRAIN , *HUMAN reproduction , *DIGITAL image processing , *MAGNETIC resonance imaging , *NEUROLOGIC examination , *PAIN measurement - Abstract
The prevalence of migraine has an exponential trajectory that is most obvious in young females between puberty and early adulthood. Adult females are affected twice as much as males. During development, hormonal changes may act on predetermined brain circuits, increasing the probability of migraine. However, little is known about the pediatric migraine brain and migraine evolution. Using magnetic resonance imaging, we evaluated 28 children with migraine (14 females and 14 males) and 28 sex-matched healthy controls to determine differences in brain structure and function between (1) females and males with migraine and (2) females and males with migraine during earlier (10-11 years) vs later (14-16 years) developmental stages compared with matched healthy controls. Compared with males, females had more gray matter in the primary somatosensory cortex (S1), supplementary motor area, precuneus, basal ganglia, and amygdala, as well as greater precuneus resting state functional connectivity to the thalamus, amygdala, and basal ganglia and greater amygdala resting state functional connectivity to the thalamus, anterior midcingulate cortex, and supplementary motor area. Moreover, older females with migraine had more gray matter in the S1, amygdala, and caudate compared to older males with migraine and matched healthy controls. This is the first study showing sex and developmental differences in pediatric migraineurs in brain regions associated with sensory, motor, and affective functions, providing insight into the neural mechanisms underlying distinct migraine sex phenotypes and their evolution that could result in important clinical implications increasing treatment effectiveness. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
24. Amygdala-frontal couplings characterizing SSRI and placebo response in social anxiety disorder.
- Author
-
Faria, Vanda, Åhs, Fredrik, Appel, Lieuwe, Linnman, Clas, Bani, Massimo, Bettica, Paolo, Pich, Emilio Merlo, Fredrikson, Mats, and Furmark, Tomas
- Subjects
AMYGDALOID body ,SOCIAL anxiety ,ANXIETY disorders ,SEROTONIN uptake inhibitors ,POSITRON emission tomography ,CEREBRAL circulation ,PREFRONTAL cortex - Abstract
In patients with social anxiety disorder (SAD) it has been reported that selective serotonin reuptake inhibitors (SSRIs) and placebo induce anxiolytic effects by attenuating neural activity in overlapping amygdala subregions, i.e. left basolateral and right ventrolateral amygdala. However, it is not known whether these treatments inhibit amygdala subregions via similar or distinct brain pathways. As anxiolytic treatments may alter amygdala-frontal couplings we investigated differences and similarities in amygdala-frontal functional co-activation patterns between responders and nonresponders to SSRIs and placebo in patients with SAD. Positron emission tomography (PET) with oxygen-15-labeled water was used to measure anxiety-related regional cerebral blood flow in 72 patients with SAD before and after 6–8 wk of treatment under double-blind conditions. Functional couplings were evaluated with a seed region approach using voxel values from the left basolateral and right ventrolateral amygdala. Responders and nonresponders to SSRIs and placebo showed different treatment-induced co-activations between the left amygdala and the dorsolateral prefrontal cortex (dlPFC) as well as the rostral anterior cingulate cortex (ACC). Conjunction analysis suggested shared anxiolysis-dependent inverse co-activations in SSRI and placebo responders between the left amygdala-dlPFC and left amygdala-rostral ACC, and a shared positive co-activation between left amygdala-dorsal ACC. We demonstrate that amygdala-frontal co-activation patterns differentiate effective from ineffective anxiolytic treatments and that SSRI and placebo responders share overlapping neuromodulatory paths that may underlie improved emotion regulation and reduced expression of anxiety.TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00343707. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
25. Amygdala Subregions Tied to SSRI and Placebo Response in Patients with Social Anxiety Disorder.
- Author
-
Faria, Vanda, Appel, Lieuwe, Åhs, Fredrik, Linnman, Clas, Pissiota, Anna, Frans, Örjan, Bani, Massimo, Bettica, Paolo, Pich, Emilio M, Jacobsson, Eva, Wahlstedt, Kurt, Fredrikson, Mats, and Furmark, Tomas
- Subjects
- *
ANXIETY disorders , *AMYGDALOID body , *SEROTONIN uptake inhibitors , *POSITRON emission tomography , *CEREBRAL circulation , *CONDITIONED response , *PLACEBOS - Abstract
The amygdala is a key structure in the pathophysiology of anxiety disorders, and a putative target for anxiolytic treatments. Selective serotonin reuptake inhibitors (SSRIs) and placebo seem to induce anxiolytic effects by attenuating amygdala responsiveness. However, conflicting amygdala findings have also been reported. Moreover, the neural profile of responders and nonresponders is insufficiently characterized and it remains unknown whether SSRIs and placebo engage common or distinct amygdala subregions or different modulatory cortical areas. We examined similarities and differences in the neural response to SSRIs and placebo in patients with social anxiety disorder (SAD). Positron emission tomography (PET) with oxygen-15-labeled water was used to assess regional cerebral blood flow (rCBF) in 72 patients with SAD during an anxiogenic public speaking task, before and after 6-8 weeks of treatment under double-blind conditions. Response rate was determined by the Clinical Global Impression-Improvement scale. Conjunction analysis revealed a common rCBF-attenuation from pre- to post-treatment in responders to SSRIs and placebo in the left basomedial/basolateral and right ventrolateral amygdala. This rCBF pattern correlated with behavioral measures of reduced anxiety and differentiated responders from nonresponders. However, nonanxiolytic treatment effects were also observed in the amygdala. All subgroups, including nonresponders, showed deactivation of the left lateral part of the amygdala. No rCBF differences were found between SSRI responders and placebo responders. This study provides new insights into the brain dynamics underlying anxiety relief by demonstrating common amygdala targets for pharmacologically and psychologically induced anxiety reduction, and by showing that the amygdala is functionally heterogeneous in anxiolysis. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
26. A Link between Serotonin-Related Gene Polymorphisms, Amygdala Activity, and Placebo-Induced Relief from Social Anxiety.
- Author
-
Furmark, Tomas, Appel, Lieuwe, Henningsson, Susanne, Åhs, Fredrik, Faria, Vanda, Linnman, Clas, Pissiota, Anna, Frans, Örjan, Bani, Massimo, Bettica, Paolo, Pich, Emilio Merlo, Jacobsson, Eva, Wahlstedt, Kurt, Oreland, Lars, Långström, Bengt, Eriksson, Elias, and Fredrikson, Mats
- Subjects
AMYGDALOID body ,PLACEBOS ,BRAIN imaging ,ANXIETY disorders ,SOCIAL anxiety ,SEROTONIN ,GENETIC polymorphisms - Abstract
Placebo may yield beneficial effects that are indistinguishable from those of active medication, but the factors underlying proneness to respond to placebo are widely unknown. Here, we used functional neuroimaging to examine neural correlates of anxiety reduction resulting from sustained placebo treatment under randomized double-blind conditions, in patients with social anxiety disorder. Brain activity was assessed during a stressful public speaking task by means of positron emission tomography before and after an 8 week treatment period. Patients were genotyped with respect to the serotonin transporter-linked polymorphic region (5-HTTLPR) and the G-703T polymorphism in the tryptophan hydroxylase-2 (TPH2) gene promoter. Results showed that placebo response was accompanied by reduced stress-related activity in the amygdala, a brain region crucial for emotional processing. However, attenuated amygdala activity was demonstrable only in subjects who were homozygous for the long allele of the 5-HTTLPR or the G variant of the TPH2 G-703T polymorphism, and not in carriers of short or T alleles. Moreover, the TPH2 polymorphism was a significant predictor of clinical placebo response, homozygosity for theGallele being associated with greater improvement in anxiety symptoms. Path analysis supported that the genetic effect on symptomatic improvement with placebo is mediated by its effect on amygdala activity. Hence, our study shows, for the first time, evidence of a link between genetically controlled serotonergic modulation of amygdala activity and placebo-induced anxiety relief. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
27. Dorsal anterior cingulate cortex activity during cognitive challenge in social anxiety disorder.
- Author
-
Wlad, Magdalena, Frick, Andreas, Engman, Jonas, Hjorth, Olof, Hoppe, Johanna M., Faria, Vanda, Wahlstedt, Kurt, Björkstrand, Johannes, Månsson, Kristoffer NT, Hultberg, Sara, Alaie, Iman, Rosén, Jörgen, Fredrikson, Mats, Furmark, Tomas, and Gingnell, Malin
- Subjects
- *
CINGULATE cortex , *ANXIETY disorders , *SOCIAL anxiety , *MENTAL depression , *FUNCTIONAL magnetic resonance imaging , *TASK performance - Abstract
Social anxiety disorder (SAD) is associated with aberrant emotional information processing while little is known about non-emotional cognitive processing biases. The dorsal anterior cingulate cortex (dACC) has been implicated in SAD neuropathology and is activated both by emotional and non-affective cognitive challenges like the Multisource Interference Task (MSIT). Here, we used fMRI to compare dACC activity and test performance during MSIT in 69 SAD patients and 38 healthy controls. In addition to patient-control comparisons, we examined whether neural activity in the dACC correlated with social anxiety, trait anxiety or depression levels. The MSIT activated the dACC as expected but with no differences in task performance or neural reactivity between SAD patients and controls. There were no significant correlations between dACC activity and social or trait anxiety symptom severity. In patients, there was a significant negative correlation between dACC activity and depressive symptoms. In absence of affective challenge, we found no disorder-related cognitive profile in SAD patients since neither MSIT task performance nor dACC neural activity deviated in patients relative to controls. • Cognitive task performance and neural activity is unaffected in social anxiety disorder. • Anxiety severity does not correlate with dorsal anterior cingulate cortex activity. • Depressive symptoms correlate with neural activity in social anxiety disorder. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
28. Enlargement of visual processing regions in social anxiety disorder is related to symptom severity.
- Author
-
Frick, Andreas, Engman, Jonas, Alaie, Iman, Björkstrand, Johannes, Faria, Vanda, Gingnell, Malin, Wallenquist, Ulrika, Agren, Thomas, Wahlstedt, Kurt, Larsson, Elna-Marie, Morell, Arvid, Fredrikson, Mats, and Furmark, Tomas
- Subjects
- *
GRAPHICS processing units , *ANXIETY disorders , *SYMPTOMS , *MORPHOMETRICS , *GRAY matter (Nerve tissue) , *CONTROL groups - Abstract
Social anxiety disorder (SAD) is associated with altered brain function and structure, but most structural studies include small samples and findings are mixed. This study compared regional gray matter volume between 48 SAD patients and 29 healthy controls (HC) as well as the relationship between volume and symptom severity. Structural magnetic resonance images from SAD patients and HC were evaluated using standard voxel-based morphometry (VBM) processing in the SPM8 software package. Social anxiety symptom severity was rated in SAD patients by a clinician using the Liebowitz Social Anxiety Scale (LSAS). SAD patients had greater regional gray matter volume in the lingual gyrus and lateral occipital cortex than the controls, and within the SAD group a positive correlation was found between symptom severity and regional gray matter volume in the lingual gyrus and the retrosplenial cortex. These findings replicate and extend earlier reports of enlarged visual processing areas in SAD. Increased gray matter volume in regions involved in visual processing and self-consciousness could underlie, or be the result of, abnormal emotional information processing and self-focused attention previously demonstrated in patients with SAD. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
29. Neuroimaging the Development of Olfactory Function in a Woman With No Olfactory Bulbs.
- Author
-
Faria V, Joshi A, Mignot C, Thaploo D, Weise S, and Hummel T
- Subjects
- Female, Humans, Neuroimaging, Magnetic Resonance Imaging, Olfactory Bulb diagnostic imaging, Olfaction Disorders etiology
- Published
- 2024
- Full Text
- View/download PDF
30. Impact of a 12-week olfactory training programme in women with migraine with aura: protocol for a double-blind, randomised, placebo-controlled trial.
- Author
-
Faria V, Dulheuer J, Joshi A, Wahl H, Klimova A, Haehner A, and Gossrau G
- Subjects
- Humans, Female, Quality of Life, Olfactory Training, Treatment Outcome, Double-Blind Method, Headache, Randomized Controlled Trials as Topic, Migraine with Aura therapy, Migraine Disorders drug therapy
- Abstract
Introduction: Migraine is a leading cause of disability and suffering worldwide. However, conventional pharmacological migraine preventive therapies are often challenging and accompanied by adverse effects. Recently, structured odour exposure has shown to successfully increase pain thresholds in patients with chronic back pain. Despite the importance of the olfactory system in migraine, there are no studies investigating the impact of structured odour exposure in patients with migraine., Methods and Analysis: This double-blind randomised placebo-controlled trial will be conducted at the Headache Clinic of the University Pain Center at TU Dresden, Germany and aims at investigating the impact of a 12-week structured exposure to odours in women with migraine. Fifty-four women between 18 and 55 years with migraine with aura will be recruited and randomised to training with odours and odourless training. The primary outcomes are mechanical and electrical pain thresholds. Secondary outcomes comprise olfactory threshold and the number of headache days. Other exploratory measurements are headache associated pain intensity, acute analgesic intake, symptoms of anxiety and depression, and quality of life. Additionally, this protocol assesses neuroanatomical and neurofunctional changes associated with the 12-week olfactory training. Data analysis will be executed on the basis of the general linear model considering repeated measurements., Ethics and Dissemination: Ethical approvals were obtained from the Ethics Board of the TU Dresden (Protocol No. BO-EK-353082020). Participation will only be possible after written informed consent is provided. Findings will be disseminated through peer-reviewed journals and scientific conferences., Trial Registration Number: DRKS00027399., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2023
- Full Text
- View/download PDF
31. Leveraging the Shared Neurobiology of Placebo Effects and Functional Neurological Disorder: A Call for Research.
- Author
-
Burke MJ, Faria V, Cappon D, Pascual-Leone A, Kaptchuk TJ, and Santarnecchi E
- Subjects
- Biomedical Research, Humans, Conversion Disorder therapy, Placebo Effect
- Published
- 2020
- Full Text
- View/download PDF
32. Do You Believe It? Verbal Suggestions Influence the Clinical and Neural Effects of Escitalopram in Social Anxiety Disorder: A Randomized Trial.
- Author
-
Faria V, Gingnell M, Hoppe JM, Hjorth O, Alaie I, Frick A, Hultberg S, Wahlstedt K, Engman J, Månsson KNT, Carlbring P, Andersson G, Reis M, Larsson EM, Fredrikson M, and Furmark T
- Subjects
- Adult, Amygdala diagnostic imaging, Amygdala drug effects, Amygdala physiopathology, Citalopram pharmacology, Drug Administration Schedule, Female, Gyrus Cinguli diagnostic imaging, Gyrus Cinguli drug effects, Gyrus Cinguli physiopathology, Humans, Magnetic Resonance Imaging, Male, Phobia, Social physiopathology, Random Allocation, Selective Serotonin Reuptake Inhibitors therapeutic use, Severity of Illness Index, Suggestion, Treatment Outcome, Young Adult, Citalopram administration & dosage, Phobia, Social diagnostic imaging, Phobia, Social drug therapy, Selective Serotonin Reuptake Inhibitors administration & dosage
- Abstract
Background: Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for depression and anxiety, but their efficacy relative to placebo has been questioned. We aimed to test how manipulation of verbally induced expectancies, central for placebo, influences SSRI treatment outcome and brain activity in patients with social anxiety disorder (SAD)., Methods: We did a randomized clinical trial, within an academic medical center (Uppsala, Sweden), of individuals fulfilling the DSM-IV criteria for SAD, recruited through media advertising. Participants were 18years or older and randomized in blocks, through a computer-generated sequence by an independent party, to nine weeks of overt or covert treatment with escitalopram (20mg daily). The overt group received correct treatment information whereas the covert group was treated deceptively with the SSRI described, by the psychiatrist, as active placebo. The treating psychiatrist was necessarily unmasked while the research staff was masked from intervention assignment. Treatment efficacy was assessed primarily with the self-rated Liebowitz Social Anxiety Scale (LSAS-SR), administered at week 0, 1, 3, 6 and 9, also yielding a dichotomous estimate of responder status (clinically significant improvement). Before and at the last week of treatment, brain activity during an emotional face-matching task was assessed with functional magnetic resonance imaging (fMRI) and during fMRI sessions, anticipatory speech anxiety was also assessed with the Spielberger State-Trait Anxiety Inventory - State version (STAI-S). Analyses included all randomized patients with outcome data at posttreatment. This study is registered at ISRCTN, number 98890605., Findings: Between March 17th 2014 and May 22nd 2015, 47 patients were recruited. One patient in the covert group dropped out after a few days of treatment and did not provide fMRI data, leaving 46 patients with complete outcome data. After nine weeks of treatment, overt (n=24) as compared to covert (n=22) SSRI administration yielded significantly better outcome on the LSAS-SR (adjusted difference 21.17, 95% CI 10.69-31.65, p<0.0001) with more than three times higher response rate (50% vs. 14%; χ
2 (1)=6.91, p=0.009) and twice the effect size (d=2.24 vs. d=1.13) from pre-to posttreatment. There was no significant between-group difference on anticipatory speech anxiety (STAI-S), both groups improving with treatment. No serious adverse reactions were recorded. On fMRI outcomes, there was suggestive evidence for a differential neural response to treatment between groups in the posterior cingulate, superior temporal and inferior frontal gyri (all z thresholds exceeding 3.68, p≤0.001). Reduced social anxiety with treatment correlated significantly with enhanced posterior cingulate (z threshold 3.24, p=0.0006) and attenuated amygdala (z threshold 2.70, p=0.003) activity., Interpretation: The clinical and neural effects of escitalopram were markedly influenced by verbal suggestions. This points to a pronounced placebo component in SSRI-treatment of SAD and favors a biopsychosocial over a biomedical explanatory model for SSRI efficacy., Funding Resources: The Swedish Research Council for Working Life and Social Research (grant 2011-1368), the Swedish Research Council (grant 421-2013-1366), Riksbankens Jubileumsfond - the Swedish Foundation for Humanities and Social Sciences (grant P13-1270:1)., (Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
33. Neuroimaging in anxiety disorders.
- Author
-
Fredrikson M and Faria V
- Subjects
- Anxiety Disorders epidemiology, Brain diagnostic imaging, Humans, Meta-Analysis as Topic, Radiography, Radionuclide Imaging, Anxiety Disorders diagnosis, Brain pathology, Neuroimaging methods
- Abstract
Neuroimaging studies using functional magnetic resonance imaging (fMRI), positron emission tomography (PET) and single-photon emission computed tomography (SPECT) to evaluate neurofunctional and neurochemical alterations related to the generation and control of affect in patients with anxiety disorders are reviewed. We performed a meta-analysis of symptom provocation studies, where neural activity was measured using fMRI, PET or SPECT to test the hypothesis that prefrontal regions modulate amygdala activity. Data revealed that reactivity in the amygdala was enhanced in patients with phobia as well as posttraumatic stress disorder (PTSD). The dorsal anterior cingulate cortex was activated in concert with the amygdala, both in PTSD and in phobic states, suggesting a role in fear expression, rather than emotional control. Activity in emotion-regulating areas in the ventromedial prefrontal cortex including the subgenual anterior cingulate cortex and the medial orbitofrontal cortex was compromised in the symptomatic state in PTSD and phobic disorders, respectively. Increased amygdala reactivity was restored with psychological treatment. Treatment effects across different modalities including pharmacological and psychological interventions as well as with placebo regimens support that reduction of neural activity in the amygdala may be a final common pathway for successful therapeutic interventions irrespective of method, thereby linking neurotransmission to plasticity in a pivotal node of the core fear network of the brain., (Copyright © 2013 S. Karger AG, Basel.)
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.